A case of ROS1‐rearranged lung adenocarcinoma exhibiting pleural effusion caused by crizotinib

Reports of crizotinib‐induced pleural effusion in non‐small cell lung cancer (NSCLC) are limited. A 35‐year‐old Japanese woman was diagnosed with ROS1‐rearranged lung adenocarcinoma (primary left lower lobe, cT4N3M1c). Crizotinib was administered as first‐line therapy, and the primary and mediastina...

Full description

Bibliographic Details

Main Authors:	Hiroaki Tachi, Kengo Nishino, Taisuke Nakaizumi, Kenya Kuramoto, Kei Shimizu, Yusuke Yamamoto, Keisuke Kobayashi, Hideo Ichimura, Akiko Sakata, Takeshi Nawa
Format:	Artigo
Language:	Inglês
Published:	Wiley 2020-07-01
Series:	Thoracic Cancer
Subjects:	Complete response crizotinib lung adenocarcinoma pleural effusion ROS1 rearrangement
Online Access:	https://doi.org/10.1111/1759-7714.13496
Tags:	Add Tag No Tags, Be the first to tag this record!